Home LiteratureArticle Details
PMID: 10498850 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Hepatocyte growth factor regulates human trophoblast motility and invasion: a role for nitric oxide.

British journal of pharmacology ·Vol. 128 ·No. 1 ·1999-09-00 ·Pages 181-9

Cartwright JE, Holden DP, Whitley GS

Abstract

1. The expression of hepatocyte growth factor (HGF) is essential for normal placental development although its function is unknown. In this study we examined the effect of HGF on trophoblast cell motility and invasion of fibrin gels and investigated the possible role of nitric oxide (NO) in this process. 2. The human extravillous trophoblast cell line SGHPL-4 express both the constitutive and inducible isoforms of nitric oxide synthase (NOS). 3. HGF significantly stimulates cell motility in monolayer culture, the invasion of fibrin gels and the production of guanosine 3':5'-cyclic monophosphate (cyclic GMP). 4. Invasion, motility and cyclic GMP production were inhibited by Ng-monomethyl-L-arginine (L-NMMA). 5. Cell motility was also significantly inhibited by the inducible NOS specific inhibitor 1400 W. 6. Neither 8 Br-cyclic GMP nor the NO donor spermine-NO had any significant effect on basal trophoblast cell motility. 7. The data presented in this study demonstrate a direct effect of trophoblast-derived NO synthesis on trophoblast cell function and support the idea that HGF is involved in the regulation of trophoblast invasion through mechanisms that involve the production of NO. However neither exogenous NO nor activation of cyclic GMP-dependent pathways alone are sufficient to stimulate trophoblast cell motility.

MeSH Terms
Arginine/analogs & derivatives,biosynthesis Cell Division/drug effects Cell Line Cell Movement/drug effects Cell Size/drug effects Cyclic GMP/biosynthesis Dose-Response Relationship, Drug Enzyme Induction/drug effects Female Fibrin/metabolism Hepatocyte Growth Factor/pharmacology Humans Integrins/analysis Interleukin-1/pharmacology Nitric Oxide/metabolism Nitric Oxide Synthase/antagonists & inhibitors,genetics,metabolism Nitric Oxide Synthase Type II RNA, Messenger/analysis,genetics Transfection Trophoblasts/cytology,drug effects,metabolism Tumor Necrosis Factor-alpha/pharmacology omega-N-Methylarginine/pharmacology
Chemicals
Integrins Interleukin-1 RNA, Messenger Tumor Necrosis Factor-alpha omega-N-Methylarginine Nitric Oxide N,N-dimethylarginine Hepatocyte Growth Factor Fibrin Arginine NOS2 protein, human Nitric Oxide Synthase Nitric Oxide Synthase Type II Cyclic GMP
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Cartwright J E
Department of Biochemistry, St. George's Hospital Medical School, Cranmer Terrace, London, SW17 ORE. j.cartwright@sghms.ac.uk
Holden D P
Whitley G S
References (38)
38 references, click to expand
  1. Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors.
    J Cell Physiol. 1987 Sep;132(3):509-16 PMID: 2443514
  2. The phagocytic activity of human first trimester extravillous trophoblast.
    Hum Reprod. 1998 Oct;13(1O):2941-9 PMID: 9804259
  3. Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro.
    Am J Pathol. 1991 Jan;138(1):37-51 PMID: 1846264
  4. Hepatocyte growth factor in human placenta and trophoblastic disease.
    Am J Pathol. 1991 Apr;138(4):1035-43 PMID: 1849357
  5. Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo.
    J Clin Invest. 1992 Jan;89(1):210-22 PMID: 1370295
  6. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.
    J Cell Biol. 1992 Nov;119(3):629-41 PMID: 1383237
  7. The interaction of HGF-SF with other cytokines in tumor invasion and angiogenesis.
    EXS. 1993;65:301-10 PMID: 7678533
  8. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts.
    J Clin Invest. 1993 Mar;91(3):950-60 PMID: 7680671
  9. Nitric oxide stimulates cyclic GMP in human thyrocytes.
    J Mol Endocrinol. 1993 Apr;10(2):163-9 PMID: 8097915
  10. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia.
    Lancet. 1993 Jul 24;342(8865):242-3 PMID: 8100963
  11. NO synthase activity in placental bed and tissues from normotensive pregnant women.
    Lancet. 1993 Sep 11;342(8872):679-80 PMID: 7689679
  12. Placental bed vessels.
    Am J Obstet Gynecol. 1973 Sep 15;117(2):294-5 PMID: 4728886
  13. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia.
    Am J Obstet Gynecol. 1993 Nov;169(5):1316-20 PMID: 8238200
  14. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide.
    Cardiovasc Res. 1993 Jul;27(7):1380-2 PMID: 7504587
  15. Endothelial nitric oxide synthase in the human placenta: regional distribution and proposed regulatory role at the feto-maternal interface.
    Placenta. 1994 Apr;15(3):257-65 PMID: 7520584
  16. Interleukin-8 and tumor necrosis factor-alpha are involved in human aortic endothelial cell migration. The possible role of these cytokines in human aortic aneurysmal blood vessel growth.
    Pathobiology. 1994;62(3):134-9 PMID: 7945919
  17. Nitric oxide activates metalloprotease enzymes in articular cartilage.
    Biochem Biophys Res Commun. 1995 Jan 5;206(1):15-21 PMID: 7529496
  18. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor.
    Nature. 1995 Feb 23;373(6516):702-5 PMID: 7854453
  19. Alterations in nitric oxide production in various forms of circulatory shock.
    New Horiz. 1995 Feb;3(1):2-32 PMID: 7535648
  20. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors.
    J Clin Invest. 1995 Jul;96(1):141-9 PMID: 7615784
  21. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud.
    Nature. 1995 Aug 31;376(6543):768-71 PMID: 7651534
  22. Stimulation of glyceraldehyde-3-phosphate dehydrogenase mRNA levels by endogenous nitric oxide in cytokine-activated endothelium.
    Biochem Biophys Res Commun. 1995 Dec 5;217(1):363-9 PMID: 8526935
  23. Nitric oxide is necessary for a switch from stationary to locomoting phenotype in epithelial cells.
    Am J Physiol. 1996 Mar;270(3 Pt 1):C794-802 PMID: 8638659
  24. Nitric oxide, the endothelium, pregnancy and pre-eclampsia.
    Br J Obstet Gynaecol. 1996 Jan;103(1):4-15 PMID: 8608097
  25. Nitric oxide inhibits migration of cultured endothelial cells.
    Biochem Biophys Res Commun. 1996 Apr 25;221(3):670-4 PMID: 8630019
  26. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo.
    J Biol Chem. 1997 Feb 21;272(8):4959-63 PMID: 9030556
  27. Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies.
    Hum Reprod. 1997 Jan;12(1):167-72 PMID: 9043923
  28. The control of blood flow to the placenta.
    Exp Physiol. 1997 Mar;82(2):377-87 PMID: 9129952
  29. Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles.
    Histol Histopathol. 1997 Apr;12(2):537-55 PMID: 9151142
  30. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?
    J Clin Invest. 1997 May 1;99(9):2139-51 PMID: 9151786
  31. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?
    J Clin Invest. 1997 May 1;99(9):2152-64 PMID: 9151787
  32. Nitric oxide in the vasculature: physiology and pathophysiology.
    Ann N Y Acad Sci. 1997 Apr 15;811:60-7; discussion 67-9 PMID: 9186585
  33. Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors.
    Cytokine Growth Factor Rev. 1997 Jun;8(2):129-42 PMID: 9244408
  34. Levels of hepatocyte growth factor and its messenger ribonucleic acid in uncomplicated pregnancies and those complicated by preeclampsia.
    J Clin Endocrinol Metab. 1997 Aug;82(8):2726-30 PMID: 9253361
  35. Comparative localization of endothelial and inducible nitric oxide synthase isoforms in haemochorial and epitheliochorial placentae.
    Placenta. 1997 Sep;18(7):511-20 PMID: 9290145
  36. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia.
    Am J Pathol. 1997 Dec;151(6):1809-18 PMID: 9403732
  37. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia.
    Am J Obstet Gynecol. 1998 Mar;178(3):551-6 PMID: 9539525
  38. Bifunctional effects of transforming growth factor-beta on migration of cultured rat aortic smooth muscle cells.
    Biochem Biophys Res Commun. 1990 Jun 15;169(2):725-9 PMID: 2357228
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
1999-09-00
Pages
181-9
Language
English
Region
England
NLM ID
7502536
PMCID
PMC1571601
Subset
IM
Grants
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com